Exchange: NASDAQ·Updated 06:13 AM EDT
MCRB logo

MCRB Seres Therapeutics Inc

$5.60
$0.04
(0.71%)
Pre-Market
Prev Close $5.64
Reported EarningsAug 5
Mkt Cap$55.07M
Vol234.00

About MCRB

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
36

Bearish Sentiment

How do you feel about MCRB?

Advertisement|Remove ads.